Aprepitant in the treatment of refractory pruritus secondary to cutaneous t-cell lymphoma;Tratamiento con aprepitant del prurito refractario secundario a linfoma cutáneo de células T

Actas Dermo-Sifiliograficas

Volumn 105, Issue 7, 2014, Pages 716-718

  Borja Consigliere, H A ^a   Lopez Pestana A ^a   Vidal Mancenido M J ^a   Tuneu Valls, A ^a  

^a HOSPITAL DONOSTIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; MORPHOLINE DERIVATIVE;

CUTANEOUS T CELL LYMPHOMA; HUMAN; NOTE; PRURITUS; CASE REPORT; COMPLICATION; FEMALE; MIDDLE AGED; SKIN TUMOR;

FEMALE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MIDDLE AGED; MORPHOLINES; PRURITUS; SKIN NEOPLASMS;

EID: 84906934748     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2013.07.007     Document Type: Letter

References (10)

1. F. Sampogna, M. Frontani, G. Baliva, G.A. Lombardo, G. Alvetreti, and C. Di Pietro et al. Quality of life and psychological distress in patients with cutaneous lymphoma Br J Dermatol 160 2009 815 822
2. S. Ständer, D. Siepmann, I. Herrgott, C. Sunderkötter, and T.A. Luger Targeting the neurokinin receptor 1 with aprepitant: A novel antipruritic strategy PLoS One 5 2010 e10968
3. U. Raap, S. Ständer, and M. Metz Pathophysiology of itch and new treatments Curr Opin Allergy Clin Immunol 11 2011 420 427
4. E.E. Carstens, M.I. Carstens, C.T. Simons, and S.L. Jinks Dorsal horn neurons expressing NK-1 receptors mediate scratching in rats Neuroreport 21 2010 303 308
5. A. Duval, and L. Dubertret Aprepitant as an antipruritic agent N Engl J Med 361 2009 1415 1416
6. N. Booken, M. Heck, J.P. Nicolay, C.D. Klemke, S. Goerdt, and J. Utikal Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma Br J Dermatol 164 2011 665 667
7. T. Torres, I. Fernandes, M. Selores, R. Alves, and M. Lima Aprepitant: Evidence of its effectiveness in patients with refractory pruritus continues J Am Acad Dermatol 66 2012 e14 e15
8. B. Ladizinski, A. Bazakas, and E.A. Olsen Aprepitant: A novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma J Am Acad Dermatol 67 2012 e198 e199
9. B. Vincenzi, M.E. Fratto, D. Santini, and G. Tonini Aprepitant against pruritus in patients with solid tumours Support Care Cancer 18 2010 1229 1230
10. B. Vincenzi, G. Tonini, and D. Santini Aprepitant for erlotinib-induced pruritus N Engl J Med 363 2010 397 398